NEJM: Latest Research & Medical Advances

Clinicians now have faster access to the latest research from the New England Journal of Medicine (NEJM), thanks to a new agreement between EBSCO Clinical Decisions and the NEJM Group. January 20, 2026, EBSCO announced that its clinical decision support solution, DynaMed®, will publish summaries of select NEJM articles in real time.

This marks a significant step in bridging the gap between medical research and patient care. Historically, clinicians faced a delay in accessing summaries of groundbreaking research published in leading journals like the NEJM. This delay could be measured in days or even weeks, potentially impacting the speed with which new evidence was integrated into clinical practice. DynaMed is now the only clinical decision support solution with licensed rights to provide same-day access to these summaries.

The Challenge of Keeping Pace with Medical Advances

The sheer volume of new medical information presents a considerable challenge for healthcare professionals. The NEJM, for over 200 years, has been a cornerstone of medical knowledge, rigorously vetting and compiling the latest research. However, even dedicated clinicians struggle to stay abreast of every new finding. The pressure to deliver the fastest possible care based on the highest quality evidence necessitates efficient access to this information.

As Roy Ziegelstein, M.D., MACP, Editor-in-Chief of DynaMed, explained, Clinicians shouldn’t have to wait days or weeks for the latest evidence. That’s why our goal continues to be closing the gap between evidence and practice. The availability of concise, actionable clinical guidance, coupled with clearly cited and expert-curated analysis, is crucial for integrating new research into patient care without delay.

How DynaMed Provides Real-Time Access

DynaMed’s new capability provides clinicians with summaries of select NEJM articles directly within the platform, on the same day of publication. This real-time access is designed to address the longstanding demand for rapid access to clinical information. The summaries are intended to provide a quick, yet thorough, overview of the research, allowing clinicians to quickly assess its relevance to their patients.

The NEJM has a long and distinguished history, having supported physicians and patients since its inception. From pioneering work on anesthesia to the latest advancements in cardiology and cancer treatment, the journal has consistently played a vital role in enhancing medical knowledge and improving patient outcomes. This partnership with DynaMed builds on that legacy by ensuring that research findings are disseminated more efficiently.

Beyond DynaMed: The NEJM Ecosystem

The NEJM Group offers a range of products designed to support clinicians and advance medical knowledge. These include NEJM itself, NEJM Clinician, NEJM Evidence, NEJM AI, NEJM Catalyst, NEJM 医学前沿, and NEJM CareerCenter. These resources provide a comprehensive suite of tools for medical professionals seeking to stay informed and improve their practice.

The Importance of Diverse Clinical Trial Participation

While access to research is critical, it’s also important to consider the quality and representativeness of the research itself. Recent discussions, also published in the NEJM, have highlighted the importance of diverse clinical trial participation. Ensuring that clinical trials include participants from a wide range of backgrounds is essential for generating evidence that is applicable to all populations.

The availability of timely research summaries, like those now offered through DynaMed and the NEJM, is a valuable tool for clinicians. However, it is crucial to remember that evidence-based medicine requires a critical appraisal of the underlying research, including consideration of its methodology and the characteristics of the study population.

This new partnership between EBSCO Clinical Decisions and the NEJM Group represents a positive development in the ongoing effort to improve the delivery of healthcare by ensuring that clinicians have access to the most current and reliable medical information.